Idexx Laboratories (IDXX) Tax Provisions (2009 - 2026)

Idexx Laboratories (IDXX) has reported Tax Provisions for 18 consecutive years, with $77.0 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Tax Provisions rose 14.23% year-over-year to $77.0 million; the TTM figure through Mar 2026 stood at $274.3 million (up 19.54% YoY), while the FY2025 annual figure was $264.7 million, up 19.26% from the prior year.
• Tax Provisions came in at $77.0 million for Q1 2026 at Idexx Laboratories, up from $58.8 million in the prior quarter.
• The five-year high for Tax Provisions was $77.0 million in Q1 2026, with the low at $39.1 million in Q2 2022.
• Average Tax Provisions over 5 years is $56.5 million, with a median of $55.8 million recorded in 2024.
• Across the five-year window, Tax Provisions decreased 20.4% in 2022 and soared 57.77% in 2023, its largest moves.
• Year by year, Tax Provisions stood at $41.0 million in 2022, then gained by 10.09% to $45.1 million in 2023, then declined by 10.87% to $40.2 million in 2024, then soared by 46.12% to $58.8 million in 2025, then jumped by 30.96% to $77.0 million in 2026.
• According to Business Quant data, Tax Provisions over the past three periods registered $77.0 million, $58.8 million, and $70.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.